Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists' perspectives.

Autor: Dahri K; Vancouver General Hospital, Vancouver, BC.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC., Sinclair Formerly MacNeil K; Faculty of Education, University of British Columbia, Vancouver, BC., Piszczek J; BC COVID Therapeutics Committee, Vancouver, BC., Wilbur K; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC., Wong B; BC Pharmacy Association, Vancouver, BC., Kuo IF; BC Ministry of Health, Government of Canada, Victoria, BC., Marra F; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC.

Publikováno v: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC [Can Pharm J (Ott)] 2024 Nov 15, pp. 17151635241288577. Date of Electronic Publication: 2024 Nov 15.